DIVALP 250mg Tablet 10x10s

Frequently asked questions

• Onset of action

  The effect of this medicine can be observed within 2 weeks of administration of the dose.

• Duration of Effect

  The amount of time for which this medicine remains active in the body is not clinically established.

• Safe with Alchohol?

  Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, difficulty in concentration, drowsiness, etc. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.

• Is it habit forming?

  No habit forming tendency has been reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to DIVALP 250mg Tablet 10x10s , or any other inactive ingredients present along with the formulation.

• Severe liver impairment

  This medicine is not recommended for use in patients with active and/or severe liver diseases.

• Urea cycle disorders

  This medicine is not recommended for use in patients with urea cycle disorder (high ammonium levels in the blood) or family history of urea cycle disorder.

• Mitochondrial disorders

  This medicine is not recommended for use in patients and children who are suspected to have the mitochondrial disorder (POLG e.g Alpers-Huttenlocher Syndrome).

• Porphyria

  This medicine is not recommended for use in patients suffering from porphyria, a disorder where there is an over-accumulation of porphyrin in the body.

• Pregnancy

  This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

• Pancreatitis

  This medicine may cause severe pancreatitis which is a serious life-threatening reaction in some patients. Discontinue the medicine if pancreatitis is detected. Report any signs and symptoms such as nausea, vomiting, or acute abdominal pain, etc. to the doctor immediately. Replacement with a suitable alternative may be required based on the clinical condition.

• Bleeding disorder

  Use with caution in patients with bleeding disorders as it may cause Thrombocytopenia. Make necessary dosage adjustments or discontinue the medicine if this condition is identified.

• Suicidal ideation

  This medicine may increase the risk of suicidal thoughts. Appropriate dose adjustments should be done in patients with depression or suicidal tendencies.

• Systemic lupus erythematosus

  This medicine should be used with caution in patients with Systemic lupus erythematosus due to the risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

• Use in elderly population

  This medicine should be used with caution in elderly patients due to the risk of dizziness.

• Impaired kidney function

  This medicine should be used with caution in patients with kidney diseases due to the increased risk of worsening of the patient's condition. Close monitoring of kidney function is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

• Weight gain

  Therapy with this medicine may cause weight gain in some patients.

• Driving and operating machinery

  This medicine may cause symptoms such as weakness, drowsiness, sleepiness, dizziness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating heavy machinery if you experience any of these symptoms.

• Thyroid function tests moderate

  This medicine may alter thyroid function tests. It is advised that you inform the doctor and the laboratory technicians about this medicine before undergoing any laboratory tests.Urine ketone test

• Urine ketone test moderate

  This medicine may lead to a false interpretation of the urine ketone test. It is advised that you inform the doctor and the laboratory technicians about this medicine before undergoing any laboratory tests.

General Instructions

Other details

References